General Principles of Antimicrobial Therapy
2011/01/31 by Surbhi Leekha, Christine L. Terrell, Randall S. Edson · 36 citations
Medicine · Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #Antibiotics Pharmacokinetics and Efficacy #Antibiotic Use and Resistance #Bacterial Identification and Susceptibility Testing
paper · pdf · doi:10.4065/mcp.2010.0639
Cited by
- Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis
- Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae
- Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
- New insights into the inhibitory roles and mechanisms of D-amino acids in bacterial biofilms in medicine, industry, and agriculture
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Antimicrobial stewardship principles in the evaluation of empirical carbapenem antibiotics in a private hospital in South Africa
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
- Antibiotics for Intra-Abdominal Infections: When, Which, How and How Long?
- External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps
- Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
- Antimicrobial resistance [wikipedia]
- Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. [europepmc]
- Antibiotics in dental practice: how justified are we. [europepmc]
- Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children. [europepmc]
- Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [europepmc]
- Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy. [europepmc]
- Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. [europepmc]
- Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. [europepmc]
- Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies. [europepmc]
- Antimicrobial Potential of Caffeic Acid against Staphylococcus aureus Clinical Strains. [europepmc]
- Phenolic Compounds Diminish Antibiotic Resistance of Staphylococcus Aureus Clinical Strains. [europepmc]
- Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI. [europepmc]
- Knowledge, practices and attitudes on antibiotics use in Cameroon: Self-medication and prescription survey among children, adolescents and adults in private pharmacies. [europepmc]
- The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms. [europepmc]
- Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation. [europepmc]
- Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy? [europepmc]
- Fever and Fever of Unknown Origin: Review, Recent Advances, and Lingering Dogma. [europepmc]
- Rapid Determination of Antimicrobial Susceptibility by Stimulated Raman Scattering Imaging of D 2 O Metabolic Incorporation in a Single Bacterium. [europepmc]
- Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health. [europepmc]
- Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship. [europepmc]
- Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae . [europepmc]
- Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance. [europepmc]
- Translating phage therapy into the clinic: Recent accomplishments but continuing challenges. [europepmc]
- Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. [europepmc]
- Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. [europepmc]
- Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review. [europepmc]